ARTICLE | Management Tracks
Amgen names Bradner CSO as Reese moves to CTO
Plus: Matthieu Coutet joins Sofinnova Partners, and updates from Vanqua Bio, Adela, Velia and more
December 15, 2023 12:53 AM UTC
James “Jay” Bradner joined Amgen Inc. (NASDAQ:AMGN) as EVP of R&D and CSO, succeeding David Reese who will become EVP and CTO. Bradner was president of the Novartis Institutes for BioMedical Research (NIBR) for nearly seven years.
Sofinnova Partners hired Matthieu Coutet as a partner, where he will contribute to the firm’s newly launched Biovelocita investment strategy for European biotech start-ups. Coutet was a managing partner at AdBio Partners...